Big news – we’re hosting our FIRST webinar on Pyridoxine-Dependent Epilepsy (PDE) research on January 25th, and you’re invited!

This blog post introduces the CHARLIE Consortium, a group of researchers dedicated to studying Pyridoxine-Dependent Epilepsy (PDE).

Here we highlight some talks that have been given by Dr. Philip Pearl who is affiliated with Boston Children’s Hospital; William G. Lennox Chair and Professor of Neurology Harvard Medical School. These talks are hosted through ICNA.

We have compiled a list of researchers we would love to hear from and want to know about the ones we have missed. We are putting together webinars and funding opportunities for those who want to make a difference in this field.

As we head into 2024, we have compiled a list of events we would like to host in the New Year.

This article was published in March of 2023 and reviews the most up-to-date progress in pyridoxine-dependent epilepsy (PDE-ALDH7A1). This section focuses on treatment options.

This article was published in March of 2023 and reviews the most up-to-date progress in pyridoxine-dependent epilepsy (PDE-ALDH7A1). This section talks about biomarkers and newborn screening.

This article was published in March of 2023 and reviews the most up-to-date progress in pyridoxine-dependent epilepsy (PDE-ALDH7A1). This section covers a summary of biochemistry and genetics.

This article was published in March of 2023 and reviews the most up-to-date progress in pyridoxine-dependent epilepsy (PDE-ALDH7A1). This section covers the clinical aspects of PDE.